Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ahn

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
International Journal of Cardiology|January 29, 2014
Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fractionDamien Gruson, Thibault Lepoutre, Sylvie A Ahn, et al.
International Journal of Cardiology|April 22, 2015
Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patientsDamien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
International Journal of Cardiology|April 9, 2016
Soluble ST2, the vitamin D/PTH axis and the heart: New interactions in the air?Damien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
Clinical Biochemistry|August 17, 2011
Measurement of NT-proBNP with LOCI technology in heart failure patientsD Gruson, Sylvie A Ahn, Thibault Lepoutre, et al.
Journal of Virology|August 10, 2000
Formation and characterization of the trimeric form of the fusion protein of Semliki Forest VirusD L Gibbons, A Ahn, P K Chatterjee, et al.
Clinical Biochemistry|June 14, 2014
Measurement of Galectin-3 with the ARCHITECT assay: Clinical validity and cost-effectiveness in patients with heart failureD Gruson, M Mancini, S A Ahn, et al.
Clinical Laboratory|February 7, 2017
Testing for Soluble ST2 in Heart Failure Patients: Reliability of a Point of Care MethodDamien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 25, 2013
Galectin-3 testing: validity of a novel automated assay in heart failure patients with reduced ejection fractionD Gruson, M Mancini, S A Ahn, et al.
Peptides|October 22, 2013
Value of proBNP1-108 testing for the risk stratification of patients with systolic heart failureDamien Gruson, Thibault Lepoutre, Sylvie A Ahn, et al.
Advances in Laboratory Medicine|June 26, 2023
Heart-type fatty acid binding protein is related to severity and established cardiac biomarkers of heart failureDamien Gruson, Christina Adamantidou, Sylvie A Ahn, et al.
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
International Journal of Cardiology|January 29, 2014
Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fractionDamien Gruson, Thibault Lepoutre, Sylvie A Ahn, et al.
International Journal of Cardiology|April 22, 2015
Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patientsDamien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
International Journal of Cardiology|April 9, 2016
Soluble ST2, the vitamin D/PTH axis and the heart: New interactions in the air?Damien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
Clinical Biochemistry|August 17, 2011
Measurement of NT-proBNP with LOCI technology in heart failure patientsD Gruson, Sylvie A Ahn, Thibault Lepoutre, et al.
Journal of Virology|August 10, 2000
Formation and characterization of the trimeric form of the fusion protein of Semliki Forest VirusD L Gibbons, A Ahn, P K Chatterjee, et al.
Clinical Biochemistry|June 14, 2014
Measurement of Galectin-3 with the ARCHITECT assay: Clinical validity and cost-effectiveness in patients with heart failureD Gruson, M Mancini, S A Ahn, et al.
Clinical Laboratory|February 7, 2017
Testing for Soluble ST2 in Heart Failure Patients: Reliability of a Point of Care MethodDamien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 25, 2013
Galectin-3 testing: validity of a novel automated assay in heart failure patients with reduced ejection fractionD Gruson, M Mancini, S A Ahn, et al.
Peptides|October 22, 2013
Value of proBNP1-108 testing for the risk stratification of patients with systolic heart failureDamien Gruson, Thibault Lepoutre, Sylvie A Ahn, et al.
Advances in Laboratory Medicine|June 26, 2023
Heart-type fatty acid binding protein is related to severity and established cardiac biomarkers of heart failureDamien Gruson, Christina Adamantidou, Sylvie A Ahn, et al.
Pageof 14